N= 56

Patients (n)
Disease (AL, MM/MG, LPD, BMF, others)
Age (years) [median (range)]
Transplant >= 2nd
Conditioning (BuCy2, Cy-ICT, Cy200 / Flu-Mel / Flu-Bu)
CD 34 + cells infused (x 106/kg) [median (range)]
CD 3 + cells infused (x 106/kg) [median (range)]
Mucositis (grade 3-4)
Microbiologically documented infections
Early acute GVHD (during admission)
Acute GVHD
Acute GVHD (II-IV)
Acute GVHD (III-IV)
Chronic GVHD
Extensive chronic GVHD
Neutrophils < 1000 x 106/L (days) [median (range)]
Neutrophils < 500 x 106/L (days) [median (range)]
Neutrophils < 100 x 106/L (days) [median (range)]
Platelets < 100 x 109/L (days) [median (range)]
Platelets < 50 x 109/L (days) [median (range)]
Platelets < 20 x 109/L (days) [median (range)]
PRBC transfusion (units)
Platelets transfusion (units)
Graft failure
Hospital stay (days) [median (range)]
ICU stay need
Follow-up (alive pts) (months) [average (range)]
Peritrasplant mortality
Day + 100 overall survival

BM-URD-Tx

PBSC-URD-Tx

46
23 / 13 / 4 / 3 / 3
44 (2-63)
50.0%
41% / 37% / 22%
2.1 (0.8-8)
20.3 (15-163)
56.5%
39.1%
10.9%
45.6%
23.9%
2.2%
23.9%
13.0%
22 (16-47)
20 (16-46)
12 (3-44)
27 (2-257)
21 (12-224)
13 (4-53)
6 (0-65)
10 (4-38)
6.5%
35 (21-67)
4.4%
22 (3.5-53.5)
6.5%
89.1%

10
5/1/4/0
32 (22-56)
50.0%
40% / 40% / 20%
9.9 (3.8-8)
348 (112-445)
70.0%
40.0%
40.0%
60.0%
60.0%
10.0%
30%
20%
20 (10-22)
19 (10-25)
13 (4-22)
25 (17-37)
19 (12-31)
15 (6-29)
10 (4-20)
15 (10-33)
0%
36 (24-56)
10%
21 (6,5-25)
10%
80.0%

--< 0,05
ns
ns
< 0,05
< 0,05
ns
ns
< 0,05
ns
< 0,05
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
ns
< 0,05
ns
ns
ns
ns
ns